Global Cannabis Pharmaceuticals Market Research Report 2026(Status and Outlook)
Cannabis pharmaceuticals refers to the development and sale of pharmaceutical drugs or medicines with compounds of cannabis plants acting as key components. The plant belongs to the Cannabaceae family of flowering plants and produces a highly popular psychoactive drug called marijuana or cannabis. The plant is indigenous to South and Central Asia. It is widely used as a recreational drug. However, in recent times, the pharmaceutical industry has invested heavily in exploring the plant and its components for their medicinal attributes. Two of the most well-researched and popular components are cannabidiol (CBD) and tetrahydrocannabinol (THC) since they are known to exhibit several therapeutic effects. Cannabis pharmaceuticals deal with exploring a combination of cannabinoids and studying their impact on diseases or health conditions under a controlled environment and in the guidance of a licensed supervisor such as a medical practitioner. Medicines produced using cannabis are available in several forms including sprays, capsules, and tablets. The medicines cannot be rolled out in the commercial market without receiving necessary approvals from regulatory bodies.
The global Cannabis Pharmaceuticals market size was estimated at USD 1319.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 13.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Cannabis Pharmaceuticals market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Cannabis Pharmaceuticals market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cannabis Pharmaceuticals market.
Global Cannabis Pharmaceuticals Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Cronos Group
Jazz Pharmaceuticals
Elixinol Wellness
Trulieve
Tilray Brands, Inc.
Cansortium Inc.
Aurora Cannabis
Canopy Growth
Cresco Labs
Organigram
Market Segmentation (by Type)
Sprays
Capsules
Tablets
Others
Market Segmentation (by Application)
Pharmacies
Hospitals
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cannabis Pharmaceuticals Market
Overview of the regional outlook of the Cannabis Pharmaceuticals Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cannabis Pharmaceuticals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cannabis Pharmaceuticals, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Cannabis Pharmaceuticals market size was estimated at USD 1319.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 13.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Cannabis Pharmaceuticals market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Cannabis Pharmaceuticals market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cannabis Pharmaceuticals market.
Global Cannabis Pharmaceuticals Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Cronos Group
Jazz Pharmaceuticals
Elixinol Wellness
Trulieve
Tilray Brands, Inc.
Cansortium Inc.
Aurora Cannabis
Canopy Growth
Cresco Labs
Organigram
Market Segmentation (by Type)
Sprays
Capsules
Tablets
Others
Market Segmentation (by Application)
Pharmacies
Hospitals
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cannabis Pharmaceuticals Market
Overview of the regional outlook of the Cannabis Pharmaceuticals Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cannabis Pharmaceuticals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cannabis Pharmaceuticals, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Cannabis Pharmaceuticals
1.2 Key Market Segments
1.2.1 Cannabis Pharmaceuticals Segment by Type
1.2.2 Cannabis Pharmaceuticals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CANNABIS PHARMACEUTICALS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cannabis Pharmaceuticals Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Cannabis Pharmaceuticals Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CANNABIS PHARMACEUTICALS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cannabis Pharmaceuticals Product Life Cycle
3.3 Global Cannabis Pharmaceuticals Sales by Manufacturers (2020-2025)
3.4 Global Cannabis Pharmaceuticals Revenue Market Share by Manufacturers (2020-2025)
3.5 Cannabis Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Cannabis Pharmaceuticals Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Cannabis Pharmaceuticals Market Competitive Situation and Trends
3.8.1 Cannabis Pharmaceuticals Market Concentration Rate
3.8.2 Global 5 and 10 Largest Cannabis Pharmaceuticals Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CANNABIS PHARMACEUTICALS INDUSTRY CHAIN ANALYSIS
4.1 Cannabis Pharmaceuticals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CANNABIS PHARMACEUTICALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cannabis Pharmaceuticals Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Cannabis Pharmaceuticals Market
5.7 ESG Ratings of Leading Companies
6 CANNABIS PHARMACEUTICALS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cannabis Pharmaceuticals Sales Market Share by Type (2020-2025)
6.3 Global Cannabis Pharmaceuticals Market Size by Type (2020-2025)
6.4 Global Cannabis Pharmaceuticals Price by Type (2020-2025)
7 CANNABIS PHARMACEUTICALS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cannabis Pharmaceuticals Market Sales by Application (2020-2025)
7.3 Global Cannabis Pharmaceuticals Market Size (M USD) by Application (2020-2025)
7.4 Global Cannabis Pharmaceuticals Sales Growth Rate by Application (2020-2025)
8 CANNABIS PHARMACEUTICALS MARKET SALES BY REGION
8.1 Global Cannabis Pharmaceuticals Sales by Region
8.1.1 Global Cannabis Pharmaceuticals Sales by Region
8.1.2 Global Cannabis Pharmaceuticals Sales Market Share by Region
8.2 Global Cannabis Pharmaceuticals Market Size by Region
8.2.1 Global Cannabis Pharmaceuticals Market Size by Region
8.2.2 Global Cannabis Pharmaceuticals Market Size by Region
8.3 North America
8.3.1 North America Cannabis Pharmaceuticals Sales by Country
8.3.2 North America Cannabis Pharmaceuticals Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Cannabis Pharmaceuticals Sales by Country
8.4.2 Europe Cannabis Pharmaceuticals Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Cannabis Pharmaceuticals Sales by Region
8.5.2 Asia Pacific Cannabis Pharmaceuticals Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Cannabis Pharmaceuticals Sales by Country
8.6.2 South America Cannabis Pharmaceuticals Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Cannabis Pharmaceuticals Sales by Region
8.7.2 Middle East and Africa Cannabis Pharmaceuticals Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CANNABIS PHARMACEUTICALS MARKET PRODUCTION BY REGION
9.1 Global Production of Cannabis Pharmaceuticals by Region(2020-2025)
9.2 Global Cannabis Pharmaceuticals Revenue Market Share by Region (2020-2025)
9.3 Global Cannabis Pharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Cannabis Pharmaceuticals Production
9.4.1 North America Cannabis Pharmaceuticals Production Growth Rate (2020-2025)
9.4.2 North America Cannabis Pharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Cannabis Pharmaceuticals Production
9.5.1 Europe Cannabis Pharmaceuticals Production Growth Rate (2020-2025)
9.5.2 Europe Cannabis Pharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Cannabis Pharmaceuticals Production (2020-2025)
9.6.1 Japan Cannabis Pharmaceuticals Production Growth Rate (2020-2025)
9.6.2 Japan Cannabis Pharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Cannabis Pharmaceuticals Production (2020-2025)
9.7.1 China Cannabis Pharmaceuticals Production Growth Rate (2020-2025)
9.7.2 China Cannabis Pharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Cronos Group
10.1.1 Cronos Group Basic Information
10.1.2 Cronos Group Cannabis Pharmaceuticals Product Overview
10.1.3 Cronos Group Cannabis Pharmaceuticals Product Market Performance
10.1.4 Cronos Group Business Overview
10.1.5 Cronos Group SWOT Analysis
10.1.6 Cronos Group Recent Developments
10.2 Jazz Pharmaceuticals
10.2.1 Jazz Pharmaceuticals Basic Information
10.2.2 Jazz Pharmaceuticals Cannabis Pharmaceuticals Product Overview
10.2.3 Jazz Pharmaceuticals Cannabis Pharmaceuticals Product Market Performance
10.2.4 Jazz Pharmaceuticals Business Overview
10.2.5 Jazz Pharmaceuticals SWOT Analysis
10.2.6 Jazz Pharmaceuticals Recent Developments
10.3 Elixinol Wellness
10.3.1 Elixinol Wellness Basic Information
10.3.2 Elixinol Wellness Cannabis Pharmaceuticals Product Overview
10.3.3 Elixinol Wellness Cannabis Pharmaceuticals Product Market Performance
10.3.4 Elixinol Wellness Business Overview
10.3.5 Elixinol Wellness SWOT Analysis
10.3.6 Elixinol Wellness Recent Developments
10.4 Trulieve
10.4.1 Trulieve Basic Information
10.4.2 Trulieve Cannabis Pharmaceuticals Product Overview
10.4.3 Trulieve Cannabis Pharmaceuticals Product Market Performance
10.4.4 Trulieve Business Overview
10.4.5 Trulieve Recent Developments
10.5 Tilray Brands, Inc.
10.5.1 Tilray Brands, Inc. Basic Information
10.5.2 Tilray Brands, Inc. Cannabis Pharmaceuticals Product Overview
10.5.3 Tilray Brands, Inc. Cannabis Pharmaceuticals Product Market Performance
10.5.4 Tilray Brands, Inc. Business Overview
10.5.5 Tilray Brands, Inc. Recent Developments
10.6 Cansortium Inc.
10.6.1 Cansortium Inc. Basic Information
10.6.2 Cansortium Inc. Cannabis Pharmaceuticals Product Overview
10.6.3 Cansortium Inc. Cannabis Pharmaceuticals Product Market Performance
10.6.4 Cansortium Inc. Business Overview
10.6.5 Cansortium Inc. Recent Developments
10.7 Aurora Cannabis
10.7.1 Aurora Cannabis Basic Information
10.7.2 Aurora Cannabis Cannabis Pharmaceuticals Product Overview
10.7.3 Aurora Cannabis Cannabis Pharmaceuticals Product Market Performance
10.7.4 Aurora Cannabis Business Overview
10.7.5 Aurora Cannabis Recent Developments
10.8 Canopy Growth
10.8.1 Canopy Growth Basic Information
10.8.2 Canopy Growth Cannabis Pharmaceuticals Product Overview
10.8.3 Canopy Growth Cannabis Pharmaceuticals Product Market Performance
10.8.4 Canopy Growth Business Overview
10.8.5 Canopy Growth Recent Developments
10.9 Cresco Labs
10.9.1 Cresco Labs Basic Information
10.9.2 Cresco Labs Cannabis Pharmaceuticals Product Overview
10.9.3 Cresco Labs Cannabis Pharmaceuticals Product Market Performance
10.9.4 Cresco Labs Business Overview
10.9.5 Cresco Labs Recent Developments
10.10 Organigram
10.10.1 Organigram Basic Information
10.10.2 Organigram Cannabis Pharmaceuticals Product Overview
10.10.3 Organigram Cannabis Pharmaceuticals Product Market Performance
10.10.4 Organigram Business Overview
10.10.5 Organigram Recent Developments
11 CANNABIS PHARMACEUTICALS MARKET FORECAST BY REGION
11.1 Global Cannabis Pharmaceuticals Market Size Forecast
11.2 Global Cannabis Pharmaceuticals Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Cannabis Pharmaceuticals Market Size Forecast by Country
11.2.3 Asia Pacific Cannabis Pharmaceuticals Market Size Forecast by Region
11.2.4 South America Cannabis Pharmaceuticals Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Cannabis Pharmaceuticals by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Cannabis Pharmaceuticals Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Cannabis Pharmaceuticals by Type (2026-2035)
12.1.2 Global Cannabis Pharmaceuticals Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Cannabis Pharmaceuticals by Type (2026-2035)
12.2 Global Cannabis Pharmaceuticals Market Forecast by Application (2026-2035)
12.2.1 Global Cannabis Pharmaceuticals Sales (K MT) Forecast by Application
12.2.2 Global Cannabis Pharmaceuticals Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Cannabis Pharmaceuticals
1.2 Key Market Segments
1.2.1 Cannabis Pharmaceuticals Segment by Type
1.2.2 Cannabis Pharmaceuticals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CANNABIS PHARMACEUTICALS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cannabis Pharmaceuticals Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Cannabis Pharmaceuticals Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CANNABIS PHARMACEUTICALS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cannabis Pharmaceuticals Product Life Cycle
3.3 Global Cannabis Pharmaceuticals Sales by Manufacturers (2020-2025)
3.4 Global Cannabis Pharmaceuticals Revenue Market Share by Manufacturers (2020-2025)
3.5 Cannabis Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Cannabis Pharmaceuticals Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Cannabis Pharmaceuticals Market Competitive Situation and Trends
3.8.1 Cannabis Pharmaceuticals Market Concentration Rate
3.8.2 Global 5 and 10 Largest Cannabis Pharmaceuticals Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CANNABIS PHARMACEUTICALS INDUSTRY CHAIN ANALYSIS
4.1 Cannabis Pharmaceuticals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CANNABIS PHARMACEUTICALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cannabis Pharmaceuticals Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Cannabis Pharmaceuticals Market
5.7 ESG Ratings of Leading Companies
6 CANNABIS PHARMACEUTICALS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cannabis Pharmaceuticals Sales Market Share by Type (2020-2025)
6.3 Global Cannabis Pharmaceuticals Market Size by Type (2020-2025)
6.4 Global Cannabis Pharmaceuticals Price by Type (2020-2025)
7 CANNABIS PHARMACEUTICALS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cannabis Pharmaceuticals Market Sales by Application (2020-2025)
7.3 Global Cannabis Pharmaceuticals Market Size (M USD) by Application (2020-2025)
7.4 Global Cannabis Pharmaceuticals Sales Growth Rate by Application (2020-2025)
8 CANNABIS PHARMACEUTICALS MARKET SALES BY REGION
8.1 Global Cannabis Pharmaceuticals Sales by Region
8.1.1 Global Cannabis Pharmaceuticals Sales by Region
8.1.2 Global Cannabis Pharmaceuticals Sales Market Share by Region
8.2 Global Cannabis Pharmaceuticals Market Size by Region
8.2.1 Global Cannabis Pharmaceuticals Market Size by Region
8.2.2 Global Cannabis Pharmaceuticals Market Size by Region
8.3 North America
8.3.1 North America Cannabis Pharmaceuticals Sales by Country
8.3.2 North America Cannabis Pharmaceuticals Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Cannabis Pharmaceuticals Sales by Country
8.4.2 Europe Cannabis Pharmaceuticals Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Cannabis Pharmaceuticals Sales by Region
8.5.2 Asia Pacific Cannabis Pharmaceuticals Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Cannabis Pharmaceuticals Sales by Country
8.6.2 South America Cannabis Pharmaceuticals Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Cannabis Pharmaceuticals Sales by Region
8.7.2 Middle East and Africa Cannabis Pharmaceuticals Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CANNABIS PHARMACEUTICALS MARKET PRODUCTION BY REGION
9.1 Global Production of Cannabis Pharmaceuticals by Region(2020-2025)
9.2 Global Cannabis Pharmaceuticals Revenue Market Share by Region (2020-2025)
9.3 Global Cannabis Pharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Cannabis Pharmaceuticals Production
9.4.1 North America Cannabis Pharmaceuticals Production Growth Rate (2020-2025)
9.4.2 North America Cannabis Pharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Cannabis Pharmaceuticals Production
9.5.1 Europe Cannabis Pharmaceuticals Production Growth Rate (2020-2025)
9.5.2 Europe Cannabis Pharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Cannabis Pharmaceuticals Production (2020-2025)
9.6.1 Japan Cannabis Pharmaceuticals Production Growth Rate (2020-2025)
9.6.2 Japan Cannabis Pharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Cannabis Pharmaceuticals Production (2020-2025)
9.7.1 China Cannabis Pharmaceuticals Production Growth Rate (2020-2025)
9.7.2 China Cannabis Pharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Cronos Group
10.1.1 Cronos Group Basic Information
10.1.2 Cronos Group Cannabis Pharmaceuticals Product Overview
10.1.3 Cronos Group Cannabis Pharmaceuticals Product Market Performance
10.1.4 Cronos Group Business Overview
10.1.5 Cronos Group SWOT Analysis
10.1.6 Cronos Group Recent Developments
10.2 Jazz Pharmaceuticals
10.2.1 Jazz Pharmaceuticals Basic Information
10.2.2 Jazz Pharmaceuticals Cannabis Pharmaceuticals Product Overview
10.2.3 Jazz Pharmaceuticals Cannabis Pharmaceuticals Product Market Performance
10.2.4 Jazz Pharmaceuticals Business Overview
10.2.5 Jazz Pharmaceuticals SWOT Analysis
10.2.6 Jazz Pharmaceuticals Recent Developments
10.3 Elixinol Wellness
10.3.1 Elixinol Wellness Basic Information
10.3.2 Elixinol Wellness Cannabis Pharmaceuticals Product Overview
10.3.3 Elixinol Wellness Cannabis Pharmaceuticals Product Market Performance
10.3.4 Elixinol Wellness Business Overview
10.3.5 Elixinol Wellness SWOT Analysis
10.3.6 Elixinol Wellness Recent Developments
10.4 Trulieve
10.4.1 Trulieve Basic Information
10.4.2 Trulieve Cannabis Pharmaceuticals Product Overview
10.4.3 Trulieve Cannabis Pharmaceuticals Product Market Performance
10.4.4 Trulieve Business Overview
10.4.5 Trulieve Recent Developments
10.5 Tilray Brands, Inc.
10.5.1 Tilray Brands, Inc. Basic Information
10.5.2 Tilray Brands, Inc. Cannabis Pharmaceuticals Product Overview
10.5.3 Tilray Brands, Inc. Cannabis Pharmaceuticals Product Market Performance
10.5.4 Tilray Brands, Inc. Business Overview
10.5.5 Tilray Brands, Inc. Recent Developments
10.6 Cansortium Inc.
10.6.1 Cansortium Inc. Basic Information
10.6.2 Cansortium Inc. Cannabis Pharmaceuticals Product Overview
10.6.3 Cansortium Inc. Cannabis Pharmaceuticals Product Market Performance
10.6.4 Cansortium Inc. Business Overview
10.6.5 Cansortium Inc. Recent Developments
10.7 Aurora Cannabis
10.7.1 Aurora Cannabis Basic Information
10.7.2 Aurora Cannabis Cannabis Pharmaceuticals Product Overview
10.7.3 Aurora Cannabis Cannabis Pharmaceuticals Product Market Performance
10.7.4 Aurora Cannabis Business Overview
10.7.5 Aurora Cannabis Recent Developments
10.8 Canopy Growth
10.8.1 Canopy Growth Basic Information
10.8.2 Canopy Growth Cannabis Pharmaceuticals Product Overview
10.8.3 Canopy Growth Cannabis Pharmaceuticals Product Market Performance
10.8.4 Canopy Growth Business Overview
10.8.5 Canopy Growth Recent Developments
10.9 Cresco Labs
10.9.1 Cresco Labs Basic Information
10.9.2 Cresco Labs Cannabis Pharmaceuticals Product Overview
10.9.3 Cresco Labs Cannabis Pharmaceuticals Product Market Performance
10.9.4 Cresco Labs Business Overview
10.9.5 Cresco Labs Recent Developments
10.10 Organigram
10.10.1 Organigram Basic Information
10.10.2 Organigram Cannabis Pharmaceuticals Product Overview
10.10.3 Organigram Cannabis Pharmaceuticals Product Market Performance
10.10.4 Organigram Business Overview
10.10.5 Organigram Recent Developments
11 CANNABIS PHARMACEUTICALS MARKET FORECAST BY REGION
11.1 Global Cannabis Pharmaceuticals Market Size Forecast
11.2 Global Cannabis Pharmaceuticals Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Cannabis Pharmaceuticals Market Size Forecast by Country
11.2.3 Asia Pacific Cannabis Pharmaceuticals Market Size Forecast by Region
11.2.4 South America Cannabis Pharmaceuticals Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Cannabis Pharmaceuticals by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Cannabis Pharmaceuticals Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Cannabis Pharmaceuticals by Type (2026-2035)
12.1.2 Global Cannabis Pharmaceuticals Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Cannabis Pharmaceuticals by Type (2026-2035)
12.2 Global Cannabis Pharmaceuticals Market Forecast by Application (2026-2035)
12.2.1 Global Cannabis Pharmaceuticals Sales (K MT) Forecast by Application
12.2.2 Global Cannabis Pharmaceuticals Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Cannabis Pharmaceuticals Market Size by Type (M USD)
Table 4. Global Cannabis Pharmaceuticals Market Size by Application
Table 5. Cannabis Pharmaceuticals Market Size Comparison by Region (M USD)
Table 6. Global Cannabis Pharmaceuticals Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Cannabis Pharmaceuticals Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Cannabis Pharmaceuticals Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Cannabis Pharmaceuticals Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cannabis Pharmaceuticals as of 2025)
Table 11. Global Market Cannabis Pharmaceuticals Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Cannabis Pharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cannabis Pharmaceuticals Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Cannabis Pharmaceuticals Sales by Type (K MT)
Table 27. Global Cannabis Pharmaceuticals Market Size by Type (M USD)
Table 28. Global Cannabis Pharmaceuticals Sales (K MT) by Type (2020-2025)
Table 29. Global Cannabis Pharmaceuticals Sales Market Share by Type (2020-2025)
Table 30. Global Cannabis Pharmaceuticals Market Size (M USD) by Type (2020-2025)
Table 31. Global Cannabis Pharmaceuticals Market Share by Type (2020-2025)
Table 32. Global Cannabis Pharmaceuticals Price (USD/KG) by Type (2020-2025)
Table 33. Global Cannabis Pharmaceuticals Sales (K MT) by Application
Table 34. Global Cannabis Pharmaceuticals Market Size by Application
Table 35. Global Cannabis Pharmaceuticals Sales by Application (2020-2025) & (K MT)
Table 36. Global Cannabis Pharmaceuticals Sales Market Share by Application (2020-2025)
Table 37. Global Cannabis Pharmaceuticals Market Size by Application (2020-2025) & (M USD)
Table 38. Global Cannabis Pharmaceuticals Market Share by Application (2020-2025)
Table 39. Global Cannabis Pharmaceuticals Sales Growth Rate by Application (2020-2025)
Table 40. Global Cannabis Pharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 41. Global Cannabis Pharmaceuticals Sales Market Share by Region (2020-2025)
Table 42. Global Cannabis Pharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 43. Global Cannabis Pharmaceuticals Market Size by Region (2020-2025)
Table 44. North America Cannabis Pharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 45. North America Cannabis Pharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Cannabis Pharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 47. Europe Cannabis Pharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Cannabis Pharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Cannabis Pharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 50. South America Cannabis Pharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 51. South America Cannabis Pharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Cannabis Pharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Cannabis Pharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 54. Global Cannabis Pharmaceuticals Production (K MT) by Region(2020-2025)
Table 55. Global Cannabis Pharmaceuticals Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Cannabis Pharmaceuticals Revenue Market Share by Region (2020-2025)
Table 57. Global Cannabis Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Cannabis Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Cannabis Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Cannabis Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Cannabis Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Cronos Group Basic Information
Table 63. Cronos Group Cannabis Pharmaceuticals Product Overview
Table 64. Cronos Group Cannabis Pharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Cronos Group Business Overview
Table 66. Cronos Group SWOT Analysis
Table 67. Cronos Group Recent Developments
Table 68. Jazz Pharmaceuticals Basic Information
Table 69. Jazz Pharmaceuticals Cannabis Pharmaceuticals Product Overview
Table 70. Jazz Pharmaceuticals Cannabis Pharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Jazz Pharmaceuticals Business Overview
Table 72. Jazz Pharmaceuticals SWOT Analysis
Table 73. Jazz Pharmaceuticals Recent Developments
Table 74. Elixinol Wellness Basic Information
Table 75. Elixinol Wellness Cannabis Pharmaceuticals Product Overview
Table 76. Elixinol Wellness Cannabis Pharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Elixinol Wellness Business Overview
Table 78. Elixinol Wellness SWOT Analysis
Table 79. Elixinol Wellness Recent Developments
Table 80. Trulieve Basic Information
Table 81. Trulieve Cannabis Pharmaceuticals Product Overview
Table 82. Trulieve Cannabis Pharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Trulieve Business Overview
Table 84. Trulieve Recent Developments
Table 85. Tilray Brands, Inc. Basic Information
Table 86. Tilray Brands, Inc. Cannabis Pharmaceuticals Product Overview
Table 87. Tilray Brands, Inc. Cannabis Pharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Tilray Brands, Inc. Business Overview
Table 89. Tilray Brands, Inc. Recent Developments
Table 90. Cansortium Inc. Basic Information
Table 91. Cansortium Inc. Cannabis Pharmaceuticals Product Overview
Table 92. Cansortium Inc. Cannabis Pharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Cansortium Inc. Business Overview
Table 94. Cansortium Inc. Recent Developments
Table 95. Aurora Cannabis Basic Information
Table 96. Aurora Cannabis Cannabis Pharmaceuticals Product Overview
Table 97. Aurora Cannabis Cannabis Pharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Aurora Cannabis Business Overview
Table 99. Aurora Cannabis Recent Developments
Table 100. Canopy Growth Basic Information
Table 101. Canopy Growth Cannabis Pharmaceuticals Product Overview
Table 102. Canopy Growth Cannabis Pharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Canopy Growth Business Overview
Table 104. Canopy Growth Recent Developments
Table 105. Cresco Labs Basic Information
Table 106. Cresco Labs Cannabis Pharmaceuticals Product Overview
Table 107. Cresco Labs Cannabis Pharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Cresco Labs Business Overview
Table 109. Cresco Labs Recent Developments
Table 110. Organigram Basic Information
Table 111. Organigram Cannabis Pharmaceuticals Product Overview
Table 112. Organigram Cannabis Pharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Organigram Business Overview
Table 114. Organigram Recent Developments
Table 115. Global Cannabis Pharmaceuticals Sales Forecast by Region (2026-2035) & (K MT)
Table 116. Global Cannabis Pharmaceuticals Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Cannabis Pharmaceuticals Sales Forecast by Country (2026-2035) & (K MT)
Table 118. North America Cannabis Pharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Cannabis Pharmaceuticals Sales Forecast by Country (2026-2035) & (K MT)
Table 120. Europe Cannabis Pharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Cannabis Pharmaceuticals Sales Forecast by Region (2026-2035) & (K MT)
Table 122. Asia Pacific Cannabis Pharmaceuticals Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Cannabis Pharmaceuticals Sales Forecast by Country (2026-2035) & (K MT)
Table 124. South America Cannabis Pharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Cannabis Pharmaceuticals Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Cannabis Pharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Cannabis Pharmaceuticals Sales Forecast by Type (2026-2035) & (K MT)
Table 128. Global Cannabis Pharmaceuticals Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Cannabis Pharmaceuticals Price Forecast by Type (2026-2035) & (USD/KG)
Table 130. Global Cannabis Pharmaceuticals Sales (K MT) Forecast by Application (2026-2035)
Table 131. Global Cannabis Pharmaceuticals Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Cannabis Pharmaceuticals Market Size by Type (M USD)
Table 4. Global Cannabis Pharmaceuticals Market Size by Application
Table 5. Cannabis Pharmaceuticals Market Size Comparison by Region (M USD)
Table 6. Global Cannabis Pharmaceuticals Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Cannabis Pharmaceuticals Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Cannabis Pharmaceuticals Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Cannabis Pharmaceuticals Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cannabis Pharmaceuticals as of 2025)
Table 11. Global Market Cannabis Pharmaceuticals Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Cannabis Pharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cannabis Pharmaceuticals Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Cannabis Pharmaceuticals Sales by Type (K MT)
Table 27. Global Cannabis Pharmaceuticals Market Size by Type (M USD)
Table 28. Global Cannabis Pharmaceuticals Sales (K MT) by Type (2020-2025)
Table 29. Global Cannabis Pharmaceuticals Sales Market Share by Type (2020-2025)
Table 30. Global Cannabis Pharmaceuticals Market Size (M USD) by Type (2020-2025)
Table 31. Global Cannabis Pharmaceuticals Market Share by Type (2020-2025)
Table 32. Global Cannabis Pharmaceuticals Price (USD/KG) by Type (2020-2025)
Table 33. Global Cannabis Pharmaceuticals Sales (K MT) by Application
Table 34. Global Cannabis Pharmaceuticals Market Size by Application
Table 35. Global Cannabis Pharmaceuticals Sales by Application (2020-2025) & (K MT)
Table 36. Global Cannabis Pharmaceuticals Sales Market Share by Application (2020-2025)
Table 37. Global Cannabis Pharmaceuticals Market Size by Application (2020-2025) & (M USD)
Table 38. Global Cannabis Pharmaceuticals Market Share by Application (2020-2025)
Table 39. Global Cannabis Pharmaceuticals Sales Growth Rate by Application (2020-2025)
Table 40. Global Cannabis Pharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 41. Global Cannabis Pharmaceuticals Sales Market Share by Region (2020-2025)
Table 42. Global Cannabis Pharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 43. Global Cannabis Pharmaceuticals Market Size by Region (2020-2025)
Table 44. North America Cannabis Pharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 45. North America Cannabis Pharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Cannabis Pharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 47. Europe Cannabis Pharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Cannabis Pharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Cannabis Pharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 50. South America Cannabis Pharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 51. South America Cannabis Pharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Cannabis Pharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Cannabis Pharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 54. Global Cannabis Pharmaceuticals Production (K MT) by Region(2020-2025)
Table 55. Global Cannabis Pharmaceuticals Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Cannabis Pharmaceuticals Revenue Market Share by Region (2020-2025)
Table 57. Global Cannabis Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Cannabis Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Cannabis Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Cannabis Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Cannabis Pharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Cronos Group Basic Information
Table 63. Cronos Group Cannabis Pharmaceuticals Product Overview
Table 64. Cronos Group Cannabis Pharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Cronos Group Business Overview
Table 66. Cronos Group SWOT Analysis
Table 67. Cronos Group Recent Developments
Table 68. Jazz Pharmaceuticals Basic Information
Table 69. Jazz Pharmaceuticals Cannabis Pharmaceuticals Product Overview
Table 70. Jazz Pharmaceuticals Cannabis Pharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Jazz Pharmaceuticals Business Overview
Table 72. Jazz Pharmaceuticals SWOT Analysis
Table 73. Jazz Pharmaceuticals Recent Developments
Table 74. Elixinol Wellness Basic Information
Table 75. Elixinol Wellness Cannabis Pharmaceuticals Product Overview
Table 76. Elixinol Wellness Cannabis Pharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Elixinol Wellness Business Overview
Table 78. Elixinol Wellness SWOT Analysis
Table 79. Elixinol Wellness Recent Developments
Table 80. Trulieve Basic Information
Table 81. Trulieve Cannabis Pharmaceuticals Product Overview
Table 82. Trulieve Cannabis Pharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Trulieve Business Overview
Table 84. Trulieve Recent Developments
Table 85. Tilray Brands, Inc. Basic Information
Table 86. Tilray Brands, Inc. Cannabis Pharmaceuticals Product Overview
Table 87. Tilray Brands, Inc. Cannabis Pharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Tilray Brands, Inc. Business Overview
Table 89. Tilray Brands, Inc. Recent Developments
Table 90. Cansortium Inc. Basic Information
Table 91. Cansortium Inc. Cannabis Pharmaceuticals Product Overview
Table 92. Cansortium Inc. Cannabis Pharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Cansortium Inc. Business Overview
Table 94. Cansortium Inc. Recent Developments
Table 95. Aurora Cannabis Basic Information
Table 96. Aurora Cannabis Cannabis Pharmaceuticals Product Overview
Table 97. Aurora Cannabis Cannabis Pharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Aurora Cannabis Business Overview
Table 99. Aurora Cannabis Recent Developments
Table 100. Canopy Growth Basic Information
Table 101. Canopy Growth Cannabis Pharmaceuticals Product Overview
Table 102. Canopy Growth Cannabis Pharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Canopy Growth Business Overview
Table 104. Canopy Growth Recent Developments
Table 105. Cresco Labs Basic Information
Table 106. Cresco Labs Cannabis Pharmaceuticals Product Overview
Table 107. Cresco Labs Cannabis Pharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Cresco Labs Business Overview
Table 109. Cresco Labs Recent Developments
Table 110. Organigram Basic Information
Table 111. Organigram Cannabis Pharmaceuticals Product Overview
Table 112. Organigram Cannabis Pharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Organigram Business Overview
Table 114. Organigram Recent Developments
Table 115. Global Cannabis Pharmaceuticals Sales Forecast by Region (2026-2035) & (K MT)
Table 116. Global Cannabis Pharmaceuticals Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Cannabis Pharmaceuticals Sales Forecast by Country (2026-2035) & (K MT)
Table 118. North America Cannabis Pharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Cannabis Pharmaceuticals Sales Forecast by Country (2026-2035) & (K MT)
Table 120. Europe Cannabis Pharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Cannabis Pharmaceuticals Sales Forecast by Region (2026-2035) & (K MT)
Table 122. Asia Pacific Cannabis Pharmaceuticals Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Cannabis Pharmaceuticals Sales Forecast by Country (2026-2035) & (K MT)
Table 124. South America Cannabis Pharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Cannabis Pharmaceuticals Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Cannabis Pharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Cannabis Pharmaceuticals Sales Forecast by Type (2026-2035) & (K MT)
Table 128. Global Cannabis Pharmaceuticals Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Cannabis Pharmaceuticals Price Forecast by Type (2026-2035) & (USD/KG)
Table 130. Global Cannabis Pharmaceuticals Sales (K MT) Forecast by Application (2026-2035)
Table 131. Global Cannabis Pharmaceuticals Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Cannabis Pharmaceuticals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cannabis Pharmaceuticals Market Size (M USD), 2025-2035
Figure 5. Global Cannabis Pharmaceuticals Market Size (M USD) (2020-2035)
Figure 6. Global Cannabis Pharmaceuticals Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cannabis Pharmaceuticals Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Cannabis Pharmaceuticals Product Life Cycle
Figure 13. Cannabis Pharmaceuticals Sales Share by Manufacturers in 2025
Figure 14. Global Cannabis Pharmaceuticals Revenue Share by Manufacturers in 2025
Figure 15. Cannabis Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Cannabis Pharmaceuticals Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Cannabis Pharmaceuticals Revenue in 2025
Figure 18. Industry Chain Map of Cannabis Pharmaceuticals
Figure 19. Global Cannabis Pharmaceuticals Market PEST Analysis
Figure 20. Global Cannabis Pharmaceuticals Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Cannabis Pharmaceuticals Market Share by Type
Figure 27. Sales Market Share of Cannabis Pharmaceuticals by Type (2020-2025)
Figure 28. Sales Market Share of Cannabis Pharmaceuticals by Type in 2025
Figure 29. Market Share of Cannabis Pharmaceuticals by Type (2020-2025)
Figure 30. Market Share of Cannabis Pharmaceuticals by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Cannabis Pharmaceuticals Market Share by Application
Figure 33. Global Cannabis Pharmaceuticals Sales Market Share by Application (2020-2025)
Figure 34. Global Cannabis Pharmaceuticals Sales Market Share by Application in 2025
Figure 35. Global Cannabis Pharmaceuticals Market Share by Application (2020-2025)
Figure 36. Global Cannabis Pharmaceuticals Market Share by Application in 2025
Figure 37. Global Cannabis Pharmaceuticals Sales Growth Rate by Application (2020-2025)
Figure 38. Global Cannabis Pharmaceuticals Sales Market Share by Region (2020-2025)
Figure 39. Global Cannabis Pharmaceuticals Market Size by Region (2020-2025)
Figure 40. North America Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Cannabis Pharmaceuticals Sales Market Share by Country in 2024
Figure 43. North America Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Cannabis Pharmaceuticals Market Size by Country in 2024
Figure 45. U.S. Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Cannabis Pharmaceuticals Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Cannabis Pharmaceuticals Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Cannabis Pharmaceuticals Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Cannabis Pharmaceuticals Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Cannabis Pharmaceuticals Sales Market Share by Country in 2024
Figure 53. Europe Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Cannabis Pharmaceuticals Market Size by Country in 2024
Figure 55. Germany Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Cannabis Pharmaceuticals Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Cannabis Pharmaceuticals Sales Market Share by Region in 2024
Figure 67. Asia Pacific Cannabis Pharmaceuticals Market Size by Region in 2024
Figure 68. China Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Cannabis Pharmaceuticals Sales and Growth Rate (K MT)
Figure 79. South America Cannabis Pharmaceuticals Sales Market Share by Country in 2024
Figure 80. South America Cannabis Pharmaceuticals Market Size and Growth Rate (M USD)
Figure 81. South America Cannabis Pharmaceuticals Market Size by Country in 2024
Figure 82. Brazil Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Cannabis Pharmaceuticals Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Cannabis Pharmaceuticals Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Cannabis Pharmaceuticals Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Cannabis Pharmaceuticals Market Size by Region in 2024
Figure 92. Saudi Arabia Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Cannabis Pharmaceuticals Production Market Share by Region (2020-2025)
Figure 103. North America Cannabis Pharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Cannabis Pharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Cannabis Pharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 106. China Cannabis Pharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Cannabis Pharmaceuticals Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Cannabis Pharmaceuticals Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Cannabis Pharmaceuticals Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Cannabis Pharmaceuticals Market Share Forecast by Type (2026-2035)
Figure 111. Global Cannabis Pharmaceuticals Sales Forecast by Application (2026-2035)
Figure 112. Global Cannabis Pharmaceuticals Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Cannabis Pharmaceuticals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cannabis Pharmaceuticals Market Size (M USD), 2025-2035
Figure 5. Global Cannabis Pharmaceuticals Market Size (M USD) (2020-2035)
Figure 6. Global Cannabis Pharmaceuticals Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cannabis Pharmaceuticals Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Cannabis Pharmaceuticals Product Life Cycle
Figure 13. Cannabis Pharmaceuticals Sales Share by Manufacturers in 2025
Figure 14. Global Cannabis Pharmaceuticals Revenue Share by Manufacturers in 2025
Figure 15. Cannabis Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Cannabis Pharmaceuticals Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Cannabis Pharmaceuticals Revenue in 2025
Figure 18. Industry Chain Map of Cannabis Pharmaceuticals
Figure 19. Global Cannabis Pharmaceuticals Market PEST Analysis
Figure 20. Global Cannabis Pharmaceuticals Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Cannabis Pharmaceuticals Market Share by Type
Figure 27. Sales Market Share of Cannabis Pharmaceuticals by Type (2020-2025)
Figure 28. Sales Market Share of Cannabis Pharmaceuticals by Type in 2025
Figure 29. Market Share of Cannabis Pharmaceuticals by Type (2020-2025)
Figure 30. Market Share of Cannabis Pharmaceuticals by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Cannabis Pharmaceuticals Market Share by Application
Figure 33. Global Cannabis Pharmaceuticals Sales Market Share by Application (2020-2025)
Figure 34. Global Cannabis Pharmaceuticals Sales Market Share by Application in 2025
Figure 35. Global Cannabis Pharmaceuticals Market Share by Application (2020-2025)
Figure 36. Global Cannabis Pharmaceuticals Market Share by Application in 2025
Figure 37. Global Cannabis Pharmaceuticals Sales Growth Rate by Application (2020-2025)
Figure 38. Global Cannabis Pharmaceuticals Sales Market Share by Region (2020-2025)
Figure 39. Global Cannabis Pharmaceuticals Market Size by Region (2020-2025)
Figure 40. North America Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Cannabis Pharmaceuticals Sales Market Share by Country in 2024
Figure 43. North America Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Cannabis Pharmaceuticals Market Size by Country in 2024
Figure 45. U.S. Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Cannabis Pharmaceuticals Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Cannabis Pharmaceuticals Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Cannabis Pharmaceuticals Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Cannabis Pharmaceuticals Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Cannabis Pharmaceuticals Sales Market Share by Country in 2024
Figure 53. Europe Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Cannabis Pharmaceuticals Market Size by Country in 2024
Figure 55. Germany Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Cannabis Pharmaceuticals Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Cannabis Pharmaceuticals Sales Market Share by Region in 2024
Figure 67. Asia Pacific Cannabis Pharmaceuticals Market Size by Region in 2024
Figure 68. China Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Cannabis Pharmaceuticals Sales and Growth Rate (K MT)
Figure 79. South America Cannabis Pharmaceuticals Sales Market Share by Country in 2024
Figure 80. South America Cannabis Pharmaceuticals Market Size and Growth Rate (M USD)
Figure 81. South America Cannabis Pharmaceuticals Market Size by Country in 2024
Figure 82. Brazil Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Cannabis Pharmaceuticals Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Cannabis Pharmaceuticals Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Cannabis Pharmaceuticals Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Cannabis Pharmaceuticals Market Size by Region in 2024
Figure 92. Saudi Arabia Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Cannabis Pharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Cannabis Pharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Cannabis Pharmaceuticals Production Market Share by Region (2020-2025)
Figure 103. North America Cannabis Pharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Cannabis Pharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Cannabis Pharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 106. China Cannabis Pharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Cannabis Pharmaceuticals Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Cannabis Pharmaceuticals Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Cannabis Pharmaceuticals Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Cannabis Pharmaceuticals Market Share Forecast by Type (2026-2035)
Figure 111. Global Cannabis Pharmaceuticals Sales Forecast by Application (2026-2035)
Figure 112. Global Cannabis Pharmaceuticals Market Share Forecast by Application (2026-2035)
